2022-1st Quarterly Review 2022 January through March
Quarterly Review 1 – 2022 COVID-19: During the first quarter of 2022, most of our employees got their 3rd or 4th dose of vaccine when the Omikron virus quickly spread. Several became positive, but none of them got seriously sick. Expansion: With the dangers of COVID-19 subsiding, we could finally implement activities that we had […]